ENLV icon

Enlivex Therapeutics
ENLV

Overview Fund Activity

9 hedge funds and large institutions have $9.47M invested in Enlivex Therapeutics in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
9
Holders Change
+9
Holders Change %
–
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
9
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VAM
1
Visium Asset Management
New York
$4.56M
2
KCM
2
Knoll Capital Management
Florida
$2.46M
3
SFM
3
Sphera Funds Management
Israel
$1.09M
4
DA
4
DSC Advisors
Illinois
$833K
5
SFM
5
Soros Fund Management
New York
$518K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
VAM
1
Visium Asset Management
New York
$4.56M 627,000 +627,000 New
KCM
2
Knoll Capital Management
Florida
$2.46M 338,110 +338,110 New
SFM
3
Sphera Funds Management
Israel
$1.09M 150,000 +150,000 New
DA
4
DSC Advisors
Illinois
$833K 114,602 +114,602 New
SFM
5
Soros Fund Management
New York
$518K 71,254 +71,254 New
GSC
6
Ground Swell Capital
South Carolina
$5K 689 +689 New
U
7
UBS
Switzerland
$4K 498 +498 New
TRCT
8
Tower Research Capital (TRC)
New York
$2K 300 +300 New
Morgan Stanley
9
Morgan Stanley
New York
$0 24 +24 New